Thank you to our speakers, sponsors, and delegates who joined us in November
for the summit!

If you are interested in the 2024 event, please get in touch at

Optimize Surveillance with Sensitive, Standardized Analytical Assays, Clinically Validated MRD Tests & Reliable ctDNA Surrogate Biomarkers to Detect Disease Earlier & Improve Patient Outcomes

The 2nd Liquid Biopsy Surveillance & Early Detection Summit returned as the industry’s only meeting showcasing biopharma-led case studies and assay developer technical progress in scaling sensitive assays that enable earlier detection and utilizing ctDNA as a surrogate biomarker to improve surveillance for a paradigm shift towards achieving personalized treatment options.

Attendees were able to stay connected and ahead of the curve with unmatched industry insights across key challenges: Sensitivity, Standardizations, Reimbursement, Clinical Utility, Multi-Cancer Early Detection, Clinical Validity, Longitudinal Monitoring

Uniting pharma, biotechs, academics, and diagnostics, this meeting was a unique opportunity to learn about the latest advancements in liquid biopsy detection and early surveillance in oncology, neurology, and rare diseases, and how they can be implemented into clinical trials and in healthy populations.

2023 Speaker Faculty Included

Aleksandra Markovets



Amanda Acerbi

Precision Medicine Global Director


Cecilia Schott

Vice President, Global Head Precision Diagnostics

Novartis AG

David Yu


Bristol Myers Squibb

Feng Liu



Gary Kelloff

Advisor to Associate Director


Minakshi Guha

LBx Strategy Lead, Precision Medicine and Companion Diagnostics

Takeda Pharmaceutical Co. Ltd.

Raluca Predoiu

Director of Precision Medicine


2023 Partners

Hear What Previous Attendees Have to Say…

“The event offered a great opportunity to network and promote my company and its services to advance the study in cancer treatment”

Translational Medicine Scientist, Burning Rock Biotech

“I really enjoyed the fact that we had the first LBx-focused summit here in the Boston area. I enjoyed networking with my fellow ex-colleagues, partners and collaborators”

LBx Strategy Lead, Precision Medicine & CDx, Takeda

“I enjoyed discussing the emerging clinical data and pathways towards clinical implantation for patient benefit”

WW Medical Lead, Bristol Myers Squibb

View the 2023 Event Guide Now!


Download your copy to find the 2023 speakers, full agenda breakdown, partners, accessing the best possible rates and to see how biopharma & academia can *secure their FREE pass

Other Events in the Series